A systematic comparison of fatigue levels in systemic sclerosis with general population, cancer and rheumatic disease samples

Brett D. Thombs, M. Bassel, L. Mcguire, Michael T Smith, M. Hudson, Jennifer Haythornthwaite

Research output: Contribution to journalArticle

Abstract

Objectives. There are no studies of fatigue levels in patients with SSc. The objective of this study was to compare fatigue in SSc to general population samples and patients with rheumatic diseases and cancer, where fatigue has been researched extensively. Methods. SSc patients completed the General Fatigue Index (GFI) of the Multidimensional Fatigue Inventory. A systematic review was conducted to select comparison samples. Mean GFI scores from SSc patients were compared with mean scores from comparison samples with t -tests and Bonferroni corrections (family-wise P <0.05). Results. A total of 106 SSc patients were sampled (97 females; 28 diffuse SSc; 11.9 ± 7.9 yrs since diagnosis). Based on comparisons from the systematic review, mean GFI scores in SSc (13.3 ± 4.6) were significantly higher (greater fatigue; P <0.05) than in two large population samples (8.7 and 9.6) and than in two samples of cancer patients in remission (9.4 and 10.0). Scores for the SSc sample were significantly lower (less fatigue) compared with two samples of cancer patients in palliative care (16.8 and 17.0). SSc GFI scores were similar to scores from patients with RA (13.4), AS (13.0) and SLE (13.1) and to scores from six studies of cancer patients in active treatment (11.1-13.5). Conclusions. The high levels of fatigue reported in SSc were similar to patients with varying types and treatment stages of cancer and patients with other rheumatic diseases when assessed with the GFI, demonstrating that fatigue warrants greater attention in SSc.

Original languageEnglish (US)
Pages (from-to)1559-1563
Number of pages5
JournalRheumatology
Volume47
Issue number10
DOIs
StatePublished - 2008

Fingerprint

Systemic Scleroderma
Rheumatic Diseases
Fatigue
Population
Neoplasms
Palliative Care

Keywords

  • Fatigue
  • Multidimensional Fatigue Inventory
  • Systematic review
  • Systemic sclerosis

ASJC Scopus subject areas

  • Rheumatology
  • Pharmacology (medical)

Cite this

A systematic comparison of fatigue levels in systemic sclerosis with general population, cancer and rheumatic disease samples. / Thombs, Brett D.; Bassel, M.; Mcguire, L.; Smith, Michael T; Hudson, M.; Haythornthwaite, Jennifer.

In: Rheumatology, Vol. 47, No. 10, 2008, p. 1559-1563.

Research output: Contribution to journalArticle

@article{f34fbc096fba4c238b8bd863f45d40fe,
title = "A systematic comparison of fatigue levels in systemic sclerosis with general population, cancer and rheumatic disease samples",
abstract = "Objectives. There are no studies of fatigue levels in patients with SSc. The objective of this study was to compare fatigue in SSc to general population samples and patients with rheumatic diseases and cancer, where fatigue has been researched extensively. Methods. SSc patients completed the General Fatigue Index (GFI) of the Multidimensional Fatigue Inventory. A systematic review was conducted to select comparison samples. Mean GFI scores from SSc patients were compared with mean scores from comparison samples with t -tests and Bonferroni corrections (family-wise P <0.05). Results. A total of 106 SSc patients were sampled (97 females; 28 diffuse SSc; 11.9 ± 7.9 yrs since diagnosis). Based on comparisons from the systematic review, mean GFI scores in SSc (13.3 ± 4.6) were significantly higher (greater fatigue; P <0.05) than in two large population samples (8.7 and 9.6) and than in two samples of cancer patients in remission (9.4 and 10.0). Scores for the SSc sample were significantly lower (less fatigue) compared with two samples of cancer patients in palliative care (16.8 and 17.0). SSc GFI scores were similar to scores from patients with RA (13.4), AS (13.0) and SLE (13.1) and to scores from six studies of cancer patients in active treatment (11.1-13.5). Conclusions. The high levels of fatigue reported in SSc were similar to patients with varying types and treatment stages of cancer and patients with other rheumatic diseases when assessed with the GFI, demonstrating that fatigue warrants greater attention in SSc.",
keywords = "Fatigue, Multidimensional Fatigue Inventory, Systematic review, Systemic sclerosis",
author = "Thombs, {Brett D.} and M. Bassel and L. Mcguire and Smith, {Michael T} and M. Hudson and Jennifer Haythornthwaite",
year = "2008",
doi = "10.1093/rheumatology/ken331",
language = "English (US)",
volume = "47",
pages = "1559--1563",
journal = "Rheumatology",
issn = "1462-0324",
publisher = "Oxford University Press",
number = "10",

}

TY - JOUR

T1 - A systematic comparison of fatigue levels in systemic sclerosis with general population, cancer and rheumatic disease samples

AU - Thombs, Brett D.

AU - Bassel, M.

AU - Mcguire, L.

AU - Smith, Michael T

AU - Hudson, M.

AU - Haythornthwaite, Jennifer

PY - 2008

Y1 - 2008

N2 - Objectives. There are no studies of fatigue levels in patients with SSc. The objective of this study was to compare fatigue in SSc to general population samples and patients with rheumatic diseases and cancer, where fatigue has been researched extensively. Methods. SSc patients completed the General Fatigue Index (GFI) of the Multidimensional Fatigue Inventory. A systematic review was conducted to select comparison samples. Mean GFI scores from SSc patients were compared with mean scores from comparison samples with t -tests and Bonferroni corrections (family-wise P <0.05). Results. A total of 106 SSc patients were sampled (97 females; 28 diffuse SSc; 11.9 ± 7.9 yrs since diagnosis). Based on comparisons from the systematic review, mean GFI scores in SSc (13.3 ± 4.6) were significantly higher (greater fatigue; P <0.05) than in two large population samples (8.7 and 9.6) and than in two samples of cancer patients in remission (9.4 and 10.0). Scores for the SSc sample were significantly lower (less fatigue) compared with two samples of cancer patients in palliative care (16.8 and 17.0). SSc GFI scores were similar to scores from patients with RA (13.4), AS (13.0) and SLE (13.1) and to scores from six studies of cancer patients in active treatment (11.1-13.5). Conclusions. The high levels of fatigue reported in SSc were similar to patients with varying types and treatment stages of cancer and patients with other rheumatic diseases when assessed with the GFI, demonstrating that fatigue warrants greater attention in SSc.

AB - Objectives. There are no studies of fatigue levels in patients with SSc. The objective of this study was to compare fatigue in SSc to general population samples and patients with rheumatic diseases and cancer, where fatigue has been researched extensively. Methods. SSc patients completed the General Fatigue Index (GFI) of the Multidimensional Fatigue Inventory. A systematic review was conducted to select comparison samples. Mean GFI scores from SSc patients were compared with mean scores from comparison samples with t -tests and Bonferroni corrections (family-wise P <0.05). Results. A total of 106 SSc patients were sampled (97 females; 28 diffuse SSc; 11.9 ± 7.9 yrs since diagnosis). Based on comparisons from the systematic review, mean GFI scores in SSc (13.3 ± 4.6) were significantly higher (greater fatigue; P <0.05) than in two large population samples (8.7 and 9.6) and than in two samples of cancer patients in remission (9.4 and 10.0). Scores for the SSc sample were significantly lower (less fatigue) compared with two samples of cancer patients in palliative care (16.8 and 17.0). SSc GFI scores were similar to scores from patients with RA (13.4), AS (13.0) and SLE (13.1) and to scores from six studies of cancer patients in active treatment (11.1-13.5). Conclusions. The high levels of fatigue reported in SSc were similar to patients with varying types and treatment stages of cancer and patients with other rheumatic diseases when assessed with the GFI, demonstrating that fatigue warrants greater attention in SSc.

KW - Fatigue

KW - Multidimensional Fatigue Inventory

KW - Systematic review

KW - Systemic sclerosis

UR - http://www.scopus.com/inward/record.url?scp=52949146043&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=52949146043&partnerID=8YFLogxK

U2 - 10.1093/rheumatology/ken331

DO - 10.1093/rheumatology/ken331

M3 - Article

C2 - 18701538

AN - SCOPUS:52949146043

VL - 47

SP - 1559

EP - 1563

JO - Rheumatology

JF - Rheumatology

SN - 1462-0324

IS - 10

ER -